We investigated confrontation naming performance of patients with Alzheimer’s disease (AD) and normal children (NC) to see if the nature of naming performance of AD patients is the reversal of that in normal development. Sixty items of the Boston Naming Test were given to 78 AD patients (and 40 age- and education-matched normal elderly) and 1,080 NC (3- to 14-year-olds). The analyses revealed that, firstly, the naming abilities of the AD patients demonstrated an inverse relationship with those of the NC. Secondly, from the clinical point of view, AD patients tended to lose vocabulary acquired later first while maintaining those acquired in earlier stages of development. Based on the findings, we claimed that this phenomenon was ‘a nominal retrogenesis’ in which ‘retrogenesis’ is ‘the process by which degenerative mechanisms reverse the order of acquisition in normal development’ as defined by Reisberg and colleagues.

1.
Vogel A, Gade A, Stokolm J, Waldemar G: Semantic memory impairment in the earliest phases of Alzheimer’s disease. Dement Geriatr Cogn Disord 2005;19:75–81.
2.
Small JA, Sandhu N: Episodic and semantic memory influences on picture naming in Alzheimer’s disease. Brain Lang 2008;104:1–9.
3.
Kim H, Kim EY, Na DL: Naming deficits in patients with dementia of the Alzheimer’s type: error analysis of Korean version-Boston Naming Test. J Korean Neurol 1997;15:1012–1021.
4.
MacKay A, Connor LT, Storandt M: Dementia does not explain correlation between age and scores on Boston Naming Test. Arch Clin Neuropsychol 2005;20:129–133.
5.
Kim H, Na DL: A normative study of the Boston Naming Test in 3- to 14-year-old Korean children. Clin Neuropsychol 2008;22:84–97.
6.
Reisberg B, Franssen EH, Hasan SM, Monteiro I, Boksay I, Souren LE, Kenowsky S, Auer SR, Elahi S, Kluger A: Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer’s and other dementing processes. Eur Arch Psychiatry Clin Neurosci 1999;249:28–36.
7.
Reisberg B, Franssen EH, Souren LEM, Auer SR, Akram I, Kenowsky S: Evidence and mechanisms of retrogenesis in Alzheimer’s and other dementias: management and treatment import. Am J Alzheimers Dis 2002;17:202–212.
8.
Stricker NH, Schweinsburg BC, Delano-Wood L, Wierenga CE, Bangen KJ, Haaland KY, Frank LR, Salmon DP, Bondi MW: Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer’s disease supports retrogenesis. Neuroimage 2009;45:10–16.
9.
Sclan SG, Reisberg B: Functional assessment staging (FAST) in the Alzheimer’s disease: reliability, validity and ordinality. Int Psychogeriatr 1992;4(suppl 1):55–69.
10.
Frisk V, Whyte H: The long-term consequences of periventricular brain damage on language and verbal memory. Dev Neuropsychol 1994;10:313–333.
11.
Kim H, Na DL: Normative data on the Korean version of the Boston Naming Test. J Clin Exp Neuropsychol 1999;21:127–133.
12.
Muller G, Richter RA, Weisbrod S, Klingberg F: Reaction time prolongation in the early stage of presenile onset Alzheimer’s disease. Eur Arch Psychiatry Clin Neurosci 1991;241:46–48.
13.
Zec RF, Markwell SJ, Burkett NR, Larsen DL: A longitudinal study of confrontation naming in the ‘normal’ elderly. J Int Neuropsychol Soc 2005;11:716–726.
14.
Iyer GK, Saccuman CM, Bates EA, Wulfeck BB: A study of age-of-acquisition (AoA) ratings in adults. CRL Newslett 2001;13:3–32.
15.
Glisky EL: Computer-assisted instruction for patients with traumatic brain injury: teaching of domain-specific knowledge. J Head Trauma Rehabil 1992;7:1–12.
16.
Obler LK, Hyun JM, Conner, PS, O’Connor B, Anema I: Brain organization of language in bilinguals; in Ardila A, Ramos E (eds): Speech and Language Disorders in Bilinguals. New York, Nova Science Publishers, 2007, pp 21–46.
17.
Gaskell MG, Dumay N: Lexical competition and the acquisition of novel words. Cognition 2003;89:105–132.
18.
Steyvers M, Tenenbaum JB: The large-scale structure of semantic networks: statistical analyses and a model of semantic growth. Cogn Sci 2005;29:41–78.
19.
Venneri A, McGeown WJ, Hietanen HM, Guerrini C, Ellis AW, Shanks MF: The anatomical bases of semantic retrieval deficits in early Alzheimer’s disease. Neuropsychologia 2008;46:497–510.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.